200 related articles for article (PubMed ID: 10730343)
1. [Controlled viral risks].
Barin F
Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
[TBL] [Abstract][Full Text] [Related]
2. [Viruses and unconventional transmissible agents: update on transmission via blood ].
Barin F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():5s-10s. PubMed ID: 10919217
[TBL] [Abstract][Full Text] [Related]
3. Genomic screening for blood-borne viruses in transfusion settings.
Lee HH; Allain JP
Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
[No Abstract] [Full Text] [Related]
4. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
[TBL] [Abstract][Full Text] [Related]
5. [Technological evolutions in blood donation screening and their impact on the residual risk].
Barlet V
Transfus Clin Biol; 2011 Apr; 18(2):292-301. PubMed ID: 21466969
[TBL] [Abstract][Full Text] [Related]
6. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
7. Fifteen years of Nucleic Acid Testing in France: Results and lessons.
Laperche S; Tiberghien P; Roche-Longin C; Pillonel J
Transfus Clin Biol; 2017 Sep; 24(3):182-188. PubMed ID: 28709845
[TBL] [Abstract][Full Text] [Related]
8. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
9. [Screening for markers of infections transmitted by transfusions in the blood collected in France from 1996 to 1998].
Couroucé AM; Pillonel J; Saura C
Transfus Clin Biol; 2000 Apr; 7(2):153-70. PubMed ID: 10812659
[TBL] [Abstract][Full Text] [Related]
10. [Screening for markers of blood-borne diseases in donated units collected in France from 1993 to 1995].
Saura C; Pillonel J; Couroucé AM
Transfus Clin Biol; 1997 Jul; 4(4):403-15. PubMed ID: 9333419
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
[TBL] [Abstract][Full Text] [Related]
12. [Ten years of nucleic acid testing: lessons and prospects].
Morel P
Transfus Clin Biol; 2011 Apr; 18(2):133-9. PubMed ID: 21397544
[TBL] [Abstract][Full Text] [Related]
13. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
Laperche S
Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
[TBL] [Abstract][Full Text] [Related]
14. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
15. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
16. [Screening for viral genomes in blood transfusion].
Coste J
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():11s-17s. PubMed ID: 10919218
[TBL] [Abstract][Full Text] [Related]
17. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
18. NAT screening of blood and plasma donations: evolution of technology and regulatory policy.
Tabor E; Epstein JS
Transfusion; 2002 Sep; 42(9):1230-7. PubMed ID: 12430684
[No Abstract] [Full Text] [Related]
19. Emerging viruses in blood transfusion.
Allain JP
Vox Sang; 1998; 74 Suppl 2():125-9. PubMed ID: 9704434
[No Abstract] [Full Text] [Related]
20. Screening for viral markers in volunteer and replacement blood donors in West Africa.
Sarkodie F; Adarkwa M; Adu-Sarkodie Y; Candotti D; Acheampong JW; Allain JP
Vox Sang; 2001 Apr; 80(3):142-7. PubMed ID: 11840974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
